This is a match-making section for JPIAMR 14th call - Disrupting drug Resistance Using Innovative Design (DRUID).
Human Health Animal Health (including wild-life, livestock, fishes, and companion animals)
in silico, in vitro, in vivo
Pharmakokinetics Pharmacodynamics PBPK pop-PK artificial intelegence
We are developing and optimizing kinetic models of metabolism, pharmacokinetics, pharmacodynamics and signaling. We are interested in the development of mechanistic physiology-based pharmacokinetic (PBPK) modeling and extrapolation to clinical predictions from nonclinical and pre-clinical data, for example, to predict minimum inhibitory concentration (MIC). The repurposing research is based on computational approaches to the analysis of data of any type, such as gene expression, genotype or proteomic data or previous PD data.
We are interested in the development of mechanistic physiology-based pharmacokinetic (PBPK) modeling and extrapolation to clinical predictions from nonclinical and pre-clinical data. Population based pharmacokietica anlyses, to investigate intra- or inter-individaul variabilities, as well as describe PK variables in population. The repurposing research based on computational approaches.
Submitted on 2022-02-01 09:04:46
« Return to the partner search tool